Department: Health Research & Policy

Dr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.

My research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.

Her research focuses on health insurance markets including the determinants and effects of individual and purchaser choices, the effects of regulation in insurance markets, the interaction of public and private systems of health insurance, and incentives for insurers to improve health care quality.

My research develops theory and methodology to perform statistical inference about the latent structure of complex systems. I am collaborating with individuals in the Cancer Center on data from phospho flow cytometry and protein arrays.

My research interests involve doctor-patient relationship and communication strategies as they pertain to (1) the development and instruction of medical Spanish curriculum, (2) satisfaction in health care delivery with emphasis on cross cultural competency issues, and (3) the effectiveness of interpretive systems in health care settings.

Dr. Desai is the Director of the Quantitative Sciences Unit. She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology. She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations.

Theories of inference applied to biostatistical data;, the bootstrap method.

Chronic disease epidemiology, particularly cancer, cardiovascular disease, adverse effects of smoking, alcohol and pharmaceuticals, evaluation of screening tests. Most of my career has been in the Kaiser Permanente Division of Research where I was Director for 7 years and am still active. I especially enjoy mentoring students and trainees at Stanford.

Health services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support integrated with electronic health records: encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records.

I am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research. Finally, I have an ongoing project related to landmark clinical trials that have had great impact.

Flexible statistical modelling, datamining, bioinformatics, and statistical computing.

My research interests include 1) The cost-effectiveness of new cardiovascular technologies. Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction. 2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring. 3) Outcomes research using existing clinical and administrative datasets. 4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).

Research interests: (1) Risk factors for age-associated cognitive decline and dementia, (2) Therapeutic strategies to improve cognitive function in aging and dementia, and (3) Brain–behavior relations as they pertain to human cognition.

My main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.

Evidence-based medicine Clinical and molecular epidemiology Human genome epidemiology Research design Reporting of research Empirical evaluation of bias in research Randomized trials Statistical methods and modeling Meta-analysis and large-scale evidence Prognosis, predictive and personalized medicine and health Sociology of science

Empirical bias/shrinkage estimation; non-parametric, smoothing; statistical inverse problems.

i am interested in cardiovascular outcomes research, particularly cardiovascular health economics.

My interests include the application of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.

Breast and gynecologic cancer genetics, epidemiology, prevention, and outcomes.

Research interests include clinical trial design, cancer biostatistics, survival analysis, adaptation and sequential experimentation, change-point detection and segmentation, stochastic optimization, time series and inference on stochastic processes, hidden Markov models and genomic applications.

Biostatistics, clinical trials, longitudinal studies, casual inference from observational studies, genetic tissue banking, informed consent. Trial designs for dynamic (adaptive) treatment regimes, psychiatric research, cancer.

Biostatistics, clinical trials, statistical evaluation of medical diagnostic tests, radiology, osteoporosis, meta-analysis, medical decisoin making

Dr. Macario is interested in the economics of health care, in particular the tradeoffs between costs and outcomes for patients having surgery and anesthesia. Dr. Macario has completed internationally recognized studies on the management of the operating room suite, as well as pioneering work on the cost-effectiveness of drugs and devices. He is Founder and Director of a Postgraduate Fellowship for physicians interested in developing their research, management, and leadership skills.

My research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.

Primary research interests: (1) genetic and environmental determinants of neurodegenerative disorders, including Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis, (2) genetic epidemiology and approaches for identifying gene-environment interactions, (3) genetic and environmental determinants of autoimmune disease.

Evaluating factors associated with racial disparities in prostate and breast cancer diagnosis, progression and survival. Evaluating genetic factors and gene/environment interactions involved in prostate and breast cancer incidence, progression and survival. Assessing quality of life and survivorship issues two or more years after diagnosis. Providing information and community-based solutions to improve public health.

My research is in statistics and their applications to medicine and biology. Many efforts have concerned tree-structured algorithms for classification, regression, survival analysis, and clustering.

My research uses decision analysis, cost-effectiveness analysis, and meta-analysis to evaluate clinical and health policy problems.

I am interested in the long-term consequences of chronic interactions between the human host and the microbial world. Recently, we have focused most heavily on Helicobacter pylori, tuberculosis and helminth infections. I also remain strongly interested in diarrheal diseases, particularly in the developing world, and in sanitation and hygiene.

My research interest focuses on the epidemiology of Parkinson’s disease and amyotrophic lateral sclerosis, specifically evaluating the genetic and environmental contributions to these neurodegenerative disorders. I am also interested in studying the relation of cognition, estradiol exposure (endogenous and exogenous), and genetic factors.

Statistical models and reasoning are key to our understanding of the genetic basis of human traits. Modern high-throughput technology presents us with new opportunities and challenges. We develop statistical approaches for high dimensional data in the attempt of improving our understanding of the molecular basis of health related traits.

Science writing, science communication, biostatistics. Research areas: osteoporosis, stress fractures, sports injuries, female athlete triad.

Genetic epidemiology; cancer epidemiology; ovarian, breast, and prostate cancer.

My research interest includes (1) Survival Analysis and Semiparametric Modeling; (2) Resampling Method ; (3) Meta Analysis ; (4) High Dimensional Data Analysis; (5) Personalized Medicine for Disease Diagnosis, Prognosis and Treatment.

My research is in applied statistics and biostatistics. I specialize in computer-intensive methods for regression and classification, bootstrap, cross-validationand statistical inference, and signal and image analysis for medical diagnosis.

Cancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers.

I study the comparative effectiveness and safety of competing clinical strategies in patients with kidney disease, diabetes, or cardiovascular disease. Such strategies may include medications, devices, clinical tests, policies, or other approaches to providing or organizing clinical care. My research is based on large insurance databases, disease registries, clinical databases or electronic medical records. My explicit career goal is to improve care and outcomes of patients with these diseases.

He is a health policy and outcomes researcher whose work has focused on children's health; health-outcomes disparities by race, ethnicity and socioeconomic status; the interaction of genetics and the environment as these factors influence child and maternal health; and the impact of medical technology on disparities in health outcomes.